|By PR Newswire||
|February 18, 2014 04:30 AM EST||
ALBANY, New York, February 18, 2014 /PRNewswire/ --
MarketResearchReports.Biz includes new market research report " Cystic Fibrosis Therapeutics In Major Developed Markets To 2019 - CFTR Modulators Initiate Drive Towards Personalized Treatment And Market Growth" to its large collection of research reports.
Research Report has released its pharma report "Cystic Fibrosis Therapeutics in Major Developed Markets to 2019 - CFTR Modulators Initiate Drive Towards Personalized Treatmsent and Market Growth." The value of the Cystic Fibrosis (CF) market is expected to increase significantly in value over the forecast period across the leading eight developed nations, from $695.6 million in 2012 to almost $4.5 billion in 2019. This equates to a Compound Annual Growth Rate (CAGR) of 30.4%. Novel treatments with disease-modifying mechanisms of action are the primary factor driving the growth of the value of the market. The positive impact of new market entrants will offset the effects of key patent losses during the forecast period.
Cystic Fibrosis Transmembrane conductance Regulators (CFTR) modulators are the first type of CF therapy to treat the root cause of the disease rather than the symptoms, and as a result, they offer patients improved relief and quality of life. Kalydeco (ivacaftor), which has been marketed since 2012, was the first CFTR modulator to reach the market, and despite only treating a small proportion of the CF population, it had a large impact on the value of the market. This effect will be repeated on a larger scale when lumacaftor and Ataluren (PTC124) enter the market, as these treatments can be used for a much larger proportion of the CF population. Vertex Pharmaceuticals Inc. are the developers of Kalydeco, lumacaftor and other early phase CFTR modulators, and are therefore expected to play a key role in the development of the future CF market.
Inquiry for more information visit: http://www.marketresearchreports.biz/analysis/186871
- A disease introduction, which defines the disease, including symptoms, diagnosis and treatment.
- An analysis of the CF marketed landscape, including a comparison of the efficacy and safety of the most prominent brands, as well as the unmet needs of CF treatment.
- A detailed analysis of the CF pipeline, detailing, among other parameters, drug distribution by phase, molecule type and mechanism of action. The CF clinical trial landscape is then analyzed, with a particular emphasis on failure rates across different trial phases as well as the trends in clinical trial size and duration. This section also includes profiles and single product forecasts for the most promising pipeline drugs.
- An epidemiological forecast of the major CF markets. The projected values include total and treated populations.
- An in-depth forecasting model for the CF market, which considers the current marketed therapies, in addition to the potential entry of new products into the market. The model consists of a projected outcome, with high and low variance results, depending on the potential performance of pipeline therapies.
To Get Download Full Report with TOC: http://www.marketresearchreports.biz/sample/sample/186871
Reasons to Buy
- Understand the CF pipeline and the clinical needs it is addressing. In particular, the importance and benefits of CFTR modulators are highlighted and compared with symptomatic treatments.
- Develop their knowledge of key products that may enter the market before 2019. Detailed profiles of these products are provided, with a focus on their clinical trial performance, as well as how they can be incorporated into the CF treatment plan and what competition they face.
- Assess the risk associated with CF clinical trials compared with both industry and therapy area averages. In addition, in order to understand the trends in both trial size and duration according to mechanism of action or molecule type.
TABLE OF CONTENT
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2.1 Disease Introduction
3 Marketed Products
3.2 Product Profiles
3.2.1 Pulmozyme (dornase alfa) - Genentech
3.2.2 Bronchitol (mannitol) - Pharmaxis
3.2.3 TOBI (tobramycin) - Novartis
3.2.4 TOBI Podhaler (tobramycin) - Novartis
3.2.5 Bramitob/Bethkis (tobramycin) - Chiesi Farmaceutici
3.2.6 Colobreathe (colistimethate sodium) - Forest Laboratories
4 Developmental Pipeline
4.2 Mechanisms of Action in the Pipeline
4.3 Clinical Trials
4.3.1 Failure Rate
4.3.2 Clinical Trial Duration
4.3.3 Clinical Trial Size
4.4 Promising Pipeline Molecules
4.4.1 Lumacaftor (VX809) - Vertex Pharmaceuticals
Glyphosate Market For Genetically Modified And Conventional Crops - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2013 - 2019
Growing demand from key end-use applications in glyphosate tolerant GM crops and conventional crops is expected to boost the global demand for glyphosate. The agriculture sector is witnessing rapid growth in Asia Pacific, Latin America and other regions, thus fuelling the demand for glyphosate. However, unfavorable factors such as emergence of glyphosate resistant weeds and stringent environmental regulations over use of agrochemicals, especially in Europe, are expected to hinder market growth. Development of innovative integrated weed management systems is expected to catch up in the near future owing to their eco friendly characteristics.
To Get Free Download Full Report With TOC: http://www.marketresearchreports.biz/sample/sample/171893
This report gives a detailed description of the global glyphosate market based on volume share (kilo tons) and revenue (USD million) for the period 2013 to 2019. The report highlights the factors contributing towards the growth of the market and the restraints that impede the market. Detailed forecasts for the years 2013-2019 for glyphosate have been given separately, for better understanding of the market scenario. The glyphosate market is described with respect to their various segments along with the opportunities that are expected in the coming six years.
For geographic analysis, the global glyphosate market has been segmented into regions such as North America, Europe, Asia Pacific, Latin America and Rest of the World (RoW) - The glyphosate market has been segmented based on the following applications - glyphosate resistant GM crops, conventional crops. The study also analyses market attractiveness based on regional segments with the help of the market attractiveness tool.
Contact Lens Market (Gas Permeable Contact Lens and Soft Contact Lens) - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
Contact lens are medical devices that offer convenience, confidence and self-esteem to the people who need vision correction. Factors such as rising ophthalmic disorders, vision problem and changing lifestyle accentuates the uptake of contact lenses during the forecast period. In addition, therapeutic, aesthetic and cosmetic are the major reasons driving the growth of contact lens market globally. The market for contact lens is segmented as by characteristics (gas-permeable and soft contact lens), by design (spherical, toric, soft, multifocal, cosmetic and orthokeratology contact lens) and by usage (corrective, therapeutic, post-operative, cosmetic, enhancement, opaque and special effect, prosthetic, computer, D-segment, sports and custom-made). The report includes market estimations of the global contact lens market in terms of value (USD million) for the period 2013 - 2019, considering 2012 as the base year. In addition, current market trends and recent developments are taken into consideration while determining the growth rate of the global contact lens market. The report provides market size and forecasts for each segment and geographic region with CAGR % for the period from 2013 to 2019.
The market is also forecasted in terms of value (USD million) for the period 2013 - 2019 for four major geographic regions, namely North America, Europe, Asia-Pacific and Rest of the World (RoW). A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the contact lens market and future opportunities are provided in the report. A PESTLE analysis has also been done while estimating individual geographies in order to provide current as well as future status. A list of recommendations for existing as well as new entrants has been discussed in the study which would help in decision making.
To Get Free Download Full Report with TOC: http://www.marketresearchreports.biz/sample/sample/187691
The global Contact Lens market is segmented into the following categories:
Contact Lens Market, by Characteristics
- Gas-Permeable Contact Lens
- Soft Contact Lens
- Daily Disposable
- Weekly Replacement
- Monthly Replacement
- Extended Wear
Contact Lens Market, by Design
- Spherical Contact Lens
- Toric Contact Lens
- Multifocal Contact Lens
Biopreservation Market (Product Types - Equipment, LIMS, And Media; Applications - Regenerative Medicine, Biobanking, And Drug Discovery) - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
This report encompasses market estimations for biopreservation market for the forecast period 2013 to 2019. The market size is forecasted considering 2012 as the base year and is represented in terms of USD million. The report caters to market players in the biopreservation industry who aspire to gain further insights into this market in terms of different product types and application markets.
The global biopreservation market is categorized on the basis of product type, application and geography. The market estimates, from the period 2011 to 2019, for each of these segments is provided in USD million.
To Get Download Full Report With TOC: http://www.marketresearchreports.biz/sample/sample/187694
The biopreservation market, by products is segmented into equipment, laboratory information management systems (LIMS) and media. The market for equipment is further analyzed as freezers, refrigerators, liquid nitrogen tanks and consumables. In addition, the media market is segmented into two types of formulations as home-brew media and pre-formulated media.
The biopreservation market, by applications is segmented into regenerative medicine, biobanking and drug discovery. Geographically, the biopreservation market is estimated and analyzed with respect to four regions namely North America, Europe, Asia-Pacific and Rest of the World.
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
90 Sate Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-997-4948
To Get Latest Reports from Same Publisher: http://www.marketresearchreports.biz/publisher/2
MongoDB Atlas leverages VPC peering for AWS, a service that allows multiple VPC networks to interact. This includes VPCs that belong to other AWS account holders. By performing cross account VPC peering, users ensure networks that host and communicate their data are secure. In his session at 20th Cloud Expo, Jay Gordon, a Developer Advocate at MongoDB, will explain how to properly architect your VPC using existing AWS tools and then peer with your MongoDB Atlas cluster. He'll discuss the secur...
Mar. 29, 2017 07:30 PM EDT Reads: 821
Things are changing so quickly in IoT that it would take a wizard to predict which ecosystem will gain the most traction. In order for IoT to reach its potential, smart devices must be able to work together. Today, there are a slew of interoperability standards being promoted by big names to make this happen: HomeKit, Brillo and Alljoyn. In his session at @ThingsExpo, Adam Justice, vice president and general manager of Grid Connect, will review what happens when smart devices don’t work togethe...
Mar. 29, 2017 06:30 PM EDT Reads: 2,725
Building a cross-cloud operational model can be a daunting task. Per-cloud silos are not the answer, but neither is a fully generic abstraction plane that strips out capabilities unique to a particular provider. In his session at 20th Cloud Expo, Chris Wolf, VP & Chief Technology Officer, Global Field & Industry at VMware, will discuss how successful organizations approach cloud operations and management, with insights into where operations should be centralized and when it’s best to decentraliz...
Mar. 29, 2017 05:15 PM EDT Reads: 3,769
SYS-CON Events announced today that Juniper Networks (NYSE: JNPR), an industry leader in automated, scalable and secure networks, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Juniper Networks challenges the status quo with products, solutions and services that transform the economics of networking. The company co-innovates with customers and partners to deliver automated, scalable and secure network...
Mar. 29, 2017 04:30 PM EDT Reads: 1,660
Deep learning has been very successful in social sciences and specially areas where there is a lot of data. Trading is another field that can be viewed as social science with a lot of data. With the advent of Deep Learning and Big Data technologies for efficient computation, we are finally able to use the same methods in investment management as we would in face recognition or in making chat-bots. In his session at 20th Cloud Expo, Gaurav Chakravorty, co-founder and Head of Strategy Development ...
Mar. 29, 2017 04:15 PM EDT Reads: 3,870
DevOps is often described as a combination of technology and culture. Without both, DevOps isn't complete. However, applying the culture to outdated technology is a recipe for disaster; as response times grow and connections between teams are delayed by technology, the culture will die. A Nutanix Enterprise Cloud has many benefits that provide the needed base for a true DevOps paradigm. In his Day 3 Keynote at 20th Cloud Expo, Chris Brown, a Solutions Marketing Manager at Nutanix, will explore t...
Mar. 29, 2017 04:00 PM EDT Reads: 3,196
Most companies are adopting or evaluating container technology - Docker in particular - to speed up application deployment, drive down cost, ease management and make application delivery more flexible overall. As with most new architectures, this dream takes a lot of work to become a reality. Even when you do get your application componentized enough and packaged properly, there are still challenges for DevOps teams to making the shift to continuous delivery and achieving that reduction in cost...
Mar. 29, 2017 03:15 PM EDT Reads: 325
SYS-CON Events announced today that SoftLayer, an IBM Company, has been named “Gold Sponsor” of SYS-CON's 18th Cloud Expo, which will take place on June 7-9, 2016, at the Javits Center in New York, New York. SoftLayer, an IBM Company, provides cloud infrastructure as a service from a growing number of data centers and network points of presence around the world. SoftLayer’s customers range from Web startups to global enterprises.
Mar. 29, 2017 03:15 PM EDT Reads: 2,242
Imagine having the ability to leverage all of your current technology and to be able to compose it into one resource pool. Now imagine, as your business grows, not having to deploy a complete new appliance to scale your infrastructure. Also imagine a true multi-cloud capability that allows live migration without any modification between cloud environments regardless of whether that cloud is your private cloud or your public AWS, Azure or Google instance. Now think of a world that is not locked i...
Mar. 29, 2017 03:15 PM EDT Reads: 751
Technology innovation is the driving force behind modern business and enterprises must respond by increasing the speed and efficiency of software delivery. The challenge is that existing enterprise applications are expensive to develop and difficult to modernize. This often results in what Gartner calls "Bimodal IT," where business struggle to apply modern tools and practices to traditional monolithic applications. But these existing assets can be modernized and made more efficient without havin...
Mar. 29, 2017 03:15 PM EDT Reads: 2,646
SYS-CON Events announced today that Auditwerx will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Auditwerx specializes in SOC 1, SOC 2, and SOC 3 attestation services throughout the U.S. and Canada. As a division of Carr, Riggs & Ingram (CRI), one of the top 20 largest CPA firms nationally, you can expect the resources, skills, and experience of a much larger firm combined with the accessibility and attent...
Mar. 29, 2017 02:30 PM EDT Reads: 731
SYS-CON Events announced today that Technologic Systems Inc., an embedded systems solutions company, will exhibit at SYS-CON's @ThingsExpo, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Technologic Systems is an embedded systems company with headquarters in Fountain Hills, Arizona. They have been in business for 32 years, helping more than 8,000 OEM customers and building over a hundred COTS products that have never been discontinued. Technologic Systems’ pr...
Mar. 29, 2017 02:30 PM EDT Reads: 3,840
SYS-CON Events announced today that CA Technologies has been named “Platinum Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY, and the 21st International Cloud Expo®, which will take place October 31-November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. CA Technologies helps customers succeed in a future where every business – from apparel to energy – is being rewritten by software. From ...
Mar. 29, 2017 02:30 PM EDT Reads: 2,295
SYS-CON Events announced today that HTBase will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. HTBase (Gartner 2016 Cool Vendor) delivers a Composable IT infrastructure solution architected for agility and increased efficiency. It turns compute, storage, and fabric into fluid pools of resources that are easily composed and re-composed to meet each application’s needs. With HTBase, companies can quickly prov...
Mar. 29, 2017 02:15 PM EDT Reads: 3,296
What if you could build a web application that could support true web-scale traffic without having to ever provision or manage a single server? Sounds magical, and it is! In his session at 20th Cloud Expo, Chris Munns, Senior Developer Advocate for Serverless Applications at Amazon Web Services, will show how to build a serverless website that scales automatically using services like AWS Lambda, Amazon API Gateway, and Amazon S3. We will review several frameworks that can help you build serverle...
Mar. 29, 2017 01:30 PM EDT Reads: 2,272